Search Results

240 results for COV

What Is a ‘News Pending’ Halt? What to Know as NNVC Stock Captivates Investors

Today, NanoViricides is grabbing a lot of attention due to a news pending halt that has sent NNVC stock skyrocketing.

TNXP Stock: The Huge Covid-19 News Boosting Tonix Pharmaceuticals Today

TNXP stock is up today with news that the company is joining with a biotech company to commercialize a new coronavirus therapy.

The Market’s Uptrend Is Under Fire

The Russell 2000 and the Nasdaq have begun to show some holes and are now perched on critical technical support.

Regeneron Pharmaceuticals Stock Shoots Up 8% on Trump Treatment

Regeneron Pharmaceuticals (REGN) stock is soaring Monday on news that its treatment for the coronavirus was used on President Trump.

7 Healthcare Stocks to Buy Now as the Pandemic Forces a Rethink

Thanks to the coronavirus pandemic, many people are rethinking the medical sector, boding well for healthcare stocks.

Use Johnson & Johnson for Quick Income

Traders need to be selective with their options, and Johnson & Johnson (NYSE:JNJ) has proven itself resilient.

7 Safe Stocks You Can Leave to Your Children

While it’s easy to get carried away with the speculation, investors should consider these safe stocks to hand down to their progeny.

The Bright Future Behind Genomic Sequencing

Recent advances in computer technology have lit a fuse under the genomic sequencing industry. And here’s what investors need to know now.

What Is Going on With Edesa Biotech (EDSA) Stock Today?

Edesa Biotech released encouraging Phase 2 results for its respiratory-syndrome-targeting antibody, thus initially boosting EDSA stock.

3 Dividend Stocks to Buy on the Dip: April 2024

The 7 Most Promising Penny Stocks to Buy in June

Top penny stocks for June look to have legitimate catalysts that can certinly send share prices higher in the coming weeks.

3 Balanced Mutual Funds for a Smooth Ride

These three balanced mutual funds aren’t just for conservative investors — they’re for anyone nervous about the stock market.

Is It Time to Dump These 4 Health Care ETFs?

These four funds’ holdings stand to lose big on health care reform, regardless of the Supreme Court ruling. Investors should assess the damage from the…

VRPX Stock: What Investors Are Saying About Virpax Pharma as Shares Continue to Fly

Shares of VRPX stock continue to blow up on Wednesday after Virpax Pharmaceuticals’ massive business announcement on Tuesday.

10 Biggest Mergers and Acquisitions of 2014

Mergers and acquisitions had a big year in 2014. Here’s a look back at the ten biggest M&A deals of 2014.

TTOO Stock: Why T2 Biosystems Is Shooting Higher Today

TTOO stock is climbing on Friday after T2 Biosystems announced its Covid-19 test can detect the Brazilian strain. What should you know?

EPWCF Stock: Why Little-Known Empower Clinics Soared Today

EPWCF stock was on the move today after Empower Clinics shared that its Covid-19 tests could detect the U.K. and South African variants.

Best Biotech Stock for 2011 – Zalicus (ZLCS)

Zalicus (NASDAQ:ZLCS) is Michael Murphy’s favorite biotech stock picks for 2011.

Novavax Stock Is Tanking Despite New Covid-19 Vaccine Authorization

NVAX stock isn’t a darling on Wall Street right now, but a rally could be just around the corner as Novavax pursues its global ambitions.

Dear Biotech Investors: Novavax’s Comparable Vaccine Matters

Researchers compared Novavax’s vaccine to three others on the market, offering a thorough glimpse of protection from boosters.

Is China’s Crackdown on Covid-19 a Concern for ContextLogic?

Whether you believe in the upside potential of WISH stock or not, China’s harsh response to the Covid-19 pandemic is worrisome.

What Is Going on With Ginkgo Bioworks (DNA) Stock Today?

Ginkgo Bioworks is trending today after crushing its Q2 earnings call this morning. DNA stock is up more than 10% on strong revenue growth.

What Are Warren Buffett and Other Billionaires’ Buying and Selling?

Warren Buffett and hedge-fund billionaires moved a lot of stock last quarter, but the most recent 13Fs showed no bold new bets worth copycatting.

The Automation Era: Why This Is the Most Mispriced Macro Shift of the Decade

AI is forcing a complete rethink of the future of work and income. It’s all part of a much larger economic shift that’s unfolding faster…

8 – 10 of 240 results